TSHA
Taysha Gene Therapies Inc.
Latest News for TSHA
Cantor Fitzgerald analyst Kristen Kluska maintained a Buy rating on Taysha Gene Therapies yesterday and set a price target of $13.00. The company’s......
Piper Sandler analyst Biren Amin maintained a Buy rating on Taysha Gene Therapies today and set a price target of $9.00. According to TipRanks, Ami......
Truist Financial analyst Joon Lee maintained a Buy rating on Taysha Gene Therapies today. The company’s shares closed yesterday at $4.27. Lee cover......
Analysts have been eager to weigh in on the Healthcare sector with new ratings on Taysha Gene Therapies (TSHA – Research Report) and Day One Biopha......
News data is sourced from MarketXLS API and updated regularly.
Showing 4 of 4 articles.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | TSHA | $4.19 | +5.0% | 4.39M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Taysha Gene Therapies Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW